| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,158 | 0,202 | 17:19 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.09. | SIPAI HEALTH (00314): COMPLETION ANNOUNCEMENT - DISCLOSEABLE TRANSACTION - ACQUISITION OF 100% EQUITY INTEREST IN JIANYI INFORMATION | - | HKEx | ||
| 10.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 07.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 3 | HKEx | ||
| 02.09. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 27.08. | SIPAI HEALTH (00314): DISCLOSEABLE TRANSACTION REDEMPTION OF WEALTH MANAGEMENT PRODUCT | - | HKEx | ||
| 26.08. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 21.08. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 20.08. | SIPAI HEALTH (00314): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 1 | HKEx | ||
| SIPAI HEALTH TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 10.08. | SIPAI HEALTH (00314): DATE OF BOARD MEETING | 2 | HKEx | ||
| 04.08. | SIPAI HEALTH (00314): POSITIVE PROFIT ALERT - TURNAROUND FROM NET LOSS TO NET PROFIT | - | HKEx | ||
| 31.07. | SIPAI HEALTH (00314): DISCLOSEABLE TRANSACTION SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT | 1 | HKEx | ||
| 16.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 15.07. | SIPAI HEALTH (00314): VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY EXECUTIVE DIRECTORS; AND ON-MARKET SHARE REPURCHASES BY THE COMPANY | - | HKEx | ||
| 13.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 08.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 06.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 30.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 2 | HKEx | ||
| 26.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 1 | HKEx | ||
| 23.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 18.06. | SIPAI HEALTH (00314): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 18, 2026 | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AETHLON MEDICAL | 7,160 | +400,70 % | Morning Market Movers: Aethlon Medical, CID HoldCo, Longeveron, Delixy See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,900 | -2,82 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,400 | +7,92 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| FRESENIUS | 45,930 | -0,46 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,600 | +0,63 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| BETA BIONICS | 21,600 | -2,62 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,74 | -0,37 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 102,00 | +4,64 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 29,340 | -3,17 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,110 | -1,05 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| ESSILORLUXOTTICA | 140,90 | -3,13 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| HEARTFLOW | 49,320 | +2,05 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,985 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| NUWELLIS, INC | 1,200 | +47,24 % | Nuwellis, Inc.: Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs | MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,290 | +2,16 % | Eckert&Ziegler-Aktie im Check am 17.09. (08:16 Uhr): Meine aktuelle Lageeinschätzung |